In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Compared to placebo, ASP2151 significantly shortens the time to healing of recurrent genital herpes, investigators report in the Journal of Infectious Diseases online…
NEW YORK (Reuters Health) – Pain associated with acute renal colic is relieved more effectively when intravenous papaverine is added to treatment with diclofenac suppository, an Iranian team…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, glycemic control is better and weight loss is sustained up to 84 weeks with exenatide once weekly…
NEW YORK (Reuters Health) – Data from the National Inpatient Sample indicate that vena cava filters reduce the in-hospital fatality rate among patients with pulmonary embolism who are…
NEW YORK (Reuters Health) – During 3 years of follow-up in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS), overall outcomes were significantly better in…
NEW YORK (Reuters Health) – Malnourished adults aged 60 and older who started an energy- and protein-enriched nutritional plan plus calcium and vitamin D supplements following hospital discharge…
NEW YORK (Reuters Health) – Giving the probiotic Lactobacillus reuteri DSM 17938 to hospitalized children is unlikely to protect them from nosocomial diarrhea, including rotavirus infection, according to…
NEW YORK (Reuters Health) – Increases in fasting blood sugar levels are often seen in patients starting niacin, sometimes to a level that suggests new onset of type…
NEW YORK (Reuters Health) – Patients receiving rehabilitation for prolonged disorders of consciousness after severe traumatic brain injury show an accelerated pace of cognitive recovery when treated with…
NEW YORK (Reuters Health) – The selective inhibitor of Janus kinase (JAK) 1 and 2, ruxolitinib, significantly reduces spleen size and other debilitating symptoms in patients with myelofibrosis…
